breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: all the criteria below should be fulfilled at the same time: 1. patients with cT1-4, cN0 breast cancer who received neoadjuvant treatment followed by SLNB with/without ALND 2. ultrasound and MRI before and after NAT available 3. imaging-guided fine needle aspiration (FNA) was necessary when suspicious lymph nodes indicated. Clinical lymph node negativity before NST is defined as no suspicion of metastasis to lymph node based on imaging results or negative result of a FNA for relevant suspicious lymph nodes. 4. patients with available peripheral blood test before any breast cancer treatment and before the definitive operation
Exclusion criteria
Exclusion criteria: 1. metastatic disease (stage IV) or bilateral breast cancer; 2. previous systemic or local anticancer therapy; 3. other malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| result of nodal status in definitive operation; | — |
Countries
People's republic of China
Contacts
the Affiliated Hospital of Southwest Medical University